Propacetamol Showed Therapeutic Equivalence for Sulpyrine

Following the KFDA’s ban on the production and sales of drugs containing terfenadine and sulpyrine due to possible harmful side effects, a recent report from the overseas clinical studies is drawing attention on the therapeutic equivalence of Propacetamol with the banned Sulpyrine.

The studies indicated that, while Propacetamol furnishes equivalent therapeutic effects, it also produces lower...